Veramarx's Seed Round

Veramarx raised a round of funding on April 18, 2017. Investors include gener8tor.

Veramarx is developing a diagnostic test for early-stage Lyme disease. Lyme disease can be treated more effectively when diagnosed shortly after a patient is infected, and tests that are currently on …

Articles about Veramarx's Seed Round: